BTIG maintains Zimmer Biomet stock with $126 target
BTIG analysts maintained their Buy rating on Zimmer Biomet (NYSE:ZBH) with a price target of $126.00 after the company ...
Zimmer Biomet Snaps Up Paragon 28 In $1.2 Billion Deal: Details
Zimmer Biomet agrees to acquire Paragon 28 for $1.1 billion, with a non-tradeable CVR up to $1 per share. Deal expected to ...
MassDevice18h
Zimmer Biomet to buy Paragon 28 for $1.2B
Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...
FierceBiotech20h
Zimmer Biomet nets foot-and-ankle specialist Paragon 28 for $1.1B
Zimmer Biomet is taking steps to expand its foot and ankle orthopedics business, with a $1.1 billion deal to acquire the ...
Zimmer Biomet’s Strategic Acquisition Prompts Hold Rating Amid Cautious Earnings Outlook
Needham analyst Michael Matson has maintained their neutral stance on ZBH stock, giving a Hold rating on January 17.Invest with Confidence: ...
journalgazette13h
Zimmer Biomet reaches agreement to acquirement Colorado-based medical device company
Zimmer Biomet Holdings, Inc. plans to acquire a Colorado-based business with "an extensive suite of surgical offerings and product systems spanning all major foot and ankle segments." ...
Zimmer Biomet's rating and oultook affirmed at Moody's as Paragon 28 deal enhances growth and diversifies business
Inc. has announced Tuesday evening plans to acquire Paragon 28, Inc. (Paragon 28), a move that Moody's (NYSE:MCO) Ratings ...
Becker's Spine Review19h
7 medtech notes: Stryker, Zimmer Biomet and more
From acquisitions to quarterly updates, here are seven key developments from spine and orthopedic devicemakers since Jan. 22.